Remote toxicologic pathology. How Deciphex is accelerating the non-clinical drug development phase w/ Donal O'Shea. - a podcast by Aleksandra Zuraw, DVM, PhD

from 2021-01-31T22:10:42.023393

:: ::

The guest of this episode is Donal O'Shea, the CEO, and founder of Deciphex. He has been active in the area of digital pathology essentially since its beginning. He worked in academia and founded several successful digital pathology start-ups before his...